In this issue:
Vedolizumab and ustekinumab concentrations in pregnant women with IBD and their infants
Fistula injections of allogeneic human amnion epithelial cells for perianal CD
Vedolizumab alters innate rather than adaptive immunity
Long-term thiamine maintenance for fatigue in IBD
Risankizumab vs. ustekinumab for moderate-to-severe CD
Guselkumab for CD
Follow-up surveillance strategies for small HCC after RFA
CADx for the resect-and-discard strategy for colorectal polyps
Intravenous vs. oral iron supplementation for anaemia after variceal bleed in cirrhosis
Odynophagia and retrosternal pain in eosinophilic oesophagitis
Please login below to download this issue (PDF)